vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and SYNCHRONOSS TECHNOLOGIES INC (SNCR). Click either name above to swap in a different company.

SYNCHRONOSS TECHNOLOGIES INC is the larger business by last-quarter revenue ($42.0M vs $24.7M, roughly 1.7× Editas Medicine, Inc.). SYNCHRONOSS TECHNOLOGIES INC runs the higher net margin — 13.8% vs -22.7%, a 36.6% gap on every dollar of revenue. On growth, SYNCHRONOSS TECHNOLOGIES INC posted the faster year-over-year revenue change (-2.2% vs -19.2%). SYNCHRONOSS TECHNOLOGIES INC produced more free cash flow last quarter ($39.0M vs $-36.4M). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 0.7%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Synchronoss Technologies Inc develops cloud-based digital transformation, subscriber management and messaging solutions for global telecom operators and enterprise clients. Its core offerings support connectivity onboarding, IoT service enablement, with key markets spanning North America, Europe and Asia-Pacific.

EDIT vs SNCR — Head-to-Head

Bigger by revenue
SNCR
SNCR
1.7× larger
SNCR
$42.0M
$24.7M
EDIT
Growing faster (revenue YoY)
SNCR
SNCR
+16.9% gap
SNCR
-2.2%
-19.2%
EDIT
Higher net margin
SNCR
SNCR
36.6% more per $
SNCR
13.8%
-22.7%
EDIT
More free cash flow
SNCR
SNCR
$75.4M more FCF
SNCR
$39.0M
$-36.4M
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
0.7%
SNCR

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
EDIT
EDIT
SNCR
SNCR
Revenue
$24.7M
$42.0M
Net Profit
$-5.6M
$5.8M
Gross Margin
79.4%
Operating Margin
-31.3%
14.0%
Net Margin
-22.7%
13.8%
Revenue YoY
-19.2%
-2.2%
Net Profit YoY
87.6%
201.7%
EPS (diluted)
$0.03
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
SNCR
SNCR
Q4 25
$24.7M
Q3 25
$7.5M
$42.0M
Q2 25
$3.6M
$42.5M
Q1 25
$4.7M
$42.2M
Q4 24
$30.6M
$44.2M
Q3 24
$61.0K
$43.0M
Q2 24
$513.0K
$43.5M
Q1 24
$1.1M
$43.0M
Net Profit
EDIT
EDIT
SNCR
SNCR
Q4 25
$-5.6M
Q3 25
$-25.1M
$5.8M
Q2 25
$-53.2M
$-19.6M
Q1 25
$-76.1M
$-3.8M
Q4 24
$-45.4M
$7.9M
Q3 24
$-62.1M
$-5.7M
Q2 24
$-67.6M
$-494.0K
Q1 24
$-62.0M
$4.5M
Gross Margin
EDIT
EDIT
SNCR
SNCR
Q4 25
Q3 25
79.4%
Q2 25
79.0%
Q1 25
79.4%
Q4 24
78.6%
Q3 24
79.1%
Q2 24
76.1%
Q1 24
76.2%
Operating Margin
EDIT
EDIT
SNCR
SNCR
Q4 25
-31.3%
Q3 25
-325.4%
14.0%
Q2 25
-1440.6%
16.1%
Q1 25
-1635.1%
19.5%
Q4 24
-152.2%
16.5%
Q3 24
-107649.2%
12.8%
Q2 24
-14016.2%
9.9%
Q1 24
-5902.3%
10.7%
Net Margin
EDIT
EDIT
SNCR
SNCR
Q4 25
-22.7%
Q3 25
-333.0%
13.8%
Q2 25
-1487.8%
-46.1%
Q1 25
-1633.5%
-9.0%
Q4 24
-148.3%
17.8%
Q3 24
-101870.5%
-13.3%
Q2 24
-13178.8%
-1.1%
Q1 24
-5458.1%
10.4%
EPS (diluted)
EDIT
EDIT
SNCR
SNCR
Q4 25
$0.03
Q3 25
$-0.28
$0.51
Q2 25
$-0.63
$-1.87
Q1 25
$-0.92
$-0.37
Q4 24
$-0.55
$0.75
Q3 24
$-0.75
$-0.56
Q2 24
$-0.82
$0.01
Q1 24
$-0.76
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
SNCR
SNCR
Cash + ST InvestmentsLiquidity on hand
$146.6M
$34.8M
Total DebtLower is stronger
$163.2M
Stockholders' EquityBook value
$27.3M
$55.4M
Total Assets
$186.5M
$278.2M
Debt / EquityLower = less leverage
2.95×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
SNCR
SNCR
Q4 25
$146.6M
Q3 25
$165.6M
$34.8M
Q2 25
$178.5M
$24.6M
Q1 25
$221.0M
$29.1M
Q4 24
$269.9M
$33.4M
Q3 24
$265.1M
$25.2M
Q2 24
$279.1M
$23.6M
Q1 24
$296.2M
$19.1M
Total Debt
EDIT
EDIT
SNCR
SNCR
Q4 25
Q3 25
$163.2M
Q2 25
$186.2M
Q1 25
$187.0M
Q4 24
$57.4M
$186.7M
Q3 24
$186.4M
Q2 24
$186.2M
Q1 24
$136.6M
Stockholders' Equity
EDIT
EDIT
SNCR
SNCR
Q4 25
$27.3M
Q3 25
$13.5M
$55.4M
Q2 25
$19.2M
$49.4M
Q1 25
$62.4M
$35.4M
Q4 24
$134.3M
$29.8M
Q3 24
$175.6M
$35.3M
Q2 24
$232.0M
$30.6M
Q1 24
$294.4M
$24.0M
Total Assets
EDIT
EDIT
SNCR
SNCR
Q4 25
$186.5M
Q3 25
$201.8M
$278.2M
Q2 25
$210.6M
$291.4M
Q1 25
$263.7M
$293.3M
Q4 24
$341.6M
$293.8M
Q3 24
$327.6M
$299.7M
Q2 24
$384.8M
$295.7M
Q1 24
$440.3M
$298.5M
Debt / Equity
EDIT
EDIT
SNCR
SNCR
Q4 25
Q3 25
2.95×
Q2 25
3.77×
Q1 25
5.28×
Q4 24
0.43×
6.27×
Q3 24
5.28×
Q2 24
6.08×
Q1 24
5.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
SNCR
SNCR
Operating Cash FlowLast quarter
$-36.4M
$39.4M
Free Cash FlowOCF − Capex
$-36.4M
$39.0M
FCF MarginFCF / Revenue
-147.3%
92.9%
Capex IntensityCapex / Revenue
0.2%
0.9%
Cash ConversionOCF / Net Profit
6.77×
TTM Free Cash FlowTrailing 4 quarters
$53.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
SNCR
SNCR
Q4 25
$-36.4M
Q3 25
$-30.8M
$39.4M
Q2 25
$-50.2M
$2.3M
Q1 25
$-47.8M
$293.0K
Q4 24
$-50.8M
$13.1M
Q3 24
$-52.6M
$3.4M
Q2 24
$-57.1M
$11.3M
Q1 24
$-49.9M
$527.0K
Free Cash Flow
EDIT
EDIT
SNCR
SNCR
Q4 25
$-36.4M
Q3 25
$-31.3M
$39.0M
Q2 25
$2.0M
Q1 25
$-47.9M
$-31.0K
Q4 24
$-51.3M
$12.2M
Q3 24
$-55.5M
$3.2M
Q2 24
$-60.6M
$10.9M
Q1 24
$-51.7M
$10.0K
FCF Margin
EDIT
EDIT
SNCR
SNCR
Q4 25
-147.3%
Q3 25
-414.6%
92.9%
Q2 25
4.6%
Q1 25
-1028.6%
-0.1%
Q4 24
-167.6%
27.6%
Q3 24
-90998.4%
7.5%
Q2 24
-11804.3%
25.2%
Q1 24
-4558.9%
0.0%
Capex Intensity
EDIT
EDIT
SNCR
SNCR
Q4 25
0.2%
Q3 25
5.7%
0.9%
Q2 25
0.0%
0.8%
Q1 25
2.4%
0.8%
Q4 24
1.8%
1.9%
Q3 24
4788.5%
0.3%
Q2 24
681.1%
0.9%
Q1 24
164.8%
1.2%
Cash Conversion
EDIT
EDIT
SNCR
SNCR
Q4 25
Q3 25
6.77×
Q2 25
Q1 25
Q4 24
1.66×
Q3 24
Q2 24
Q1 24
0.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EDIT
EDIT

Segment breakdown not available.

SNCR
SNCR

Subscription Services$39.4M94%
Professional Services$2.6M6%

Related Comparisons